A novel receptor tyrosine-protein kinase erbB-2 (HER2)-binding affiprobe – named Z HER2:342 -RLuc – was designed, produced and assessed in terms of function to detect HER2 positive cells and for preliminary clinical diagnosis.
No takes yet. Share an insight, caveat, or question.
Nazari et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: